Muñoz-Baez, Paloma; Illescas-López, Marta; de-Salazar, Adolfo; Falcés-Romero, Iker; Pinto, Adriana; Portilla, Irene; Masia, Mar; Peraire, Joaquim; Alemán-Valls, María-Remedios; Sanchiz, Marta; Iborra-Bendicho, María-Asunción; Baza, Begoña; Aguilera, Antonio; Olalla, Julian; Espinosa, Nuria; Iribarren, José-Antonio; Gisbert, Laura; Imaz, Arkaitz; Montero, Marta; Navarro-Marcotegui, María; Suárez-García, Inés; Riera, Melchor; Pérez-Elias, María-Jesús; Galán, Juan-Carlos; García-Fraile, Lucio-Jesus; Sanz, José; Ibarra-Ugarte, Sofía; Bernal-Morell, Enrique; Blanco, José-Ramon; Navarro, Gemma; Martínez-Madrid, Onofre; Viciana-Ramos, María-Isabel; Mohamen-Balghata, Mohamed-Omar; Delgado, Elena; Thompson, Michael-M; Moreno, Cristina; Fuentes, Ana; García, Federico
(OXFORD UNIV PRESS, 2026-06-02)
BACKGROUND: While surveillance drug resistance mutations (SDRMs) remain essential for monitoring transmitted drug resistance (TDR), the clinical impact of transmitted resistance for current first-line regimens has become ...